Picture of Xbrane Biopharma AB logo

XBRANE — Xbrane Biopharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Xbrane confirms order of Spherotide to value of SEK 8.5 million

Sept 11 (Reuters) - XBRANE BIOPHARMA AB  XBRANE.ST : 
    * REG-XBRANE CONFIRMS ORDER OF SPHEROTIDE TO VALUE OF SEK 8.5 MILLION AND MORE THAN 10,000 
DOSES SOLD 
    * CONFIRMS ADDITIONAL ORDER OF SPHEROTIDE FROM POOYESH DAROU TO A VALUE OF SEK 8.5 MILLION 
TO BE DELIVERED IN Q4 2017 
 
Source text for Eikon:  ID:nGNE96ss0  
Further company coverage:  XBRANE.ST  
 
 (Gdynia Newsroom) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Xbrane Biopharma AB

See all news